Cart
sales@molnova.com
3-O-p-Coumaroylquinic acid
CAS No. 5746-55-4
3-O-p-Coumaroylquinic acid( —— )
Catalog No. M29439 CAS No. 5746-55-4
3-O-p-Coumaroylquinic acid, hydroxycinnamic acid derivative, is isolated from a 70% methanolic Crataegus extract (Crataegi folium cum flore).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 291 | Get Quote |
|
| 10MG | 431 | Get Quote |
|
| 25MG | 709 | Get Quote |
|
| 50MG | 972 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Name3-O-p-Coumaroylquinic acid
-
NoteResearch use only, not for human use.
-
Brief Description3-O-p-Coumaroylquinic acid, hydroxycinnamic acid derivative, is isolated from a 70% methanolic Crataegus extract (Crataegi folium cum flore).
-
Description3-O-p-Coumaroylquinic acid, hydroxycinnamic acid derivative, is isolated from a 70% methanolic Crataegus extract (Crataegi folium cum flore).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5746-55-4
-
Formula Weight674.6
-
Molecular FormulaC32H34O16
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@H](C[C@](C[C@H]1OC(/C=C/c(cc2)ccc2O)=O)(C(O)=O)O)[C@H]1OO[C@H](C[C@](C[C@H]1OC(/C=C/c(cc2)ccc2O)=O)(C(O)=O)O)[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Licochalcone B
Licochalcone B (LCB) inhibits the proliferation of human malignant bladder cancer cell lines (T24 and EJ) in vitro and antitumor activity in vivo in MB49 (murine bladder cancer cell line) tumor model.
-
Oleanonic?Acid
Oleanolic acid is relatively non-toxic, hepatoprotective, and exhibits?antitumor and?andantiviral?properties.
-
Scutebarbatine A
Scutebarbatine A shows significant antitumor effects on A549 cells in vivo and in vitro via mitochondria-mediated apoptosis by up-regulating expressions of caspase-3 and 9, and down-regulating Bcl-2.
